Genmab — April 2020
-
Darzalex 937M USD
-
Johnson & Johnson Reports 2020 First-Quarter Results
/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2020. The Company also announced earlier today that its Board of...
(www.prnewswire.com)
-
No one-time revenue this time?
-
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2020
Company Announcement Net sales of DARZALEX® in the first quarter of 2020 totaled USD 937 millionGenmab will receive royalties on worldwide sales from...
GlobeNewswire News Room (www.globenewswire.com)
-
Thanks E L. That's quite important
-
STÆRKT!!:-)
-
Det er faktisk overraskende flot. Når Jan direkte har været ude at forberede marekdet på en mulig nedjustering af salgs forventninger
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind